Article information
Full text is only aviable in PDF
Bibliografía
[1]
American College of Chest Physicians, National Heart, Lung, and Blood Institute. National Conference on Oxygen Therapy. Chest. 1984;86:234-47. Published concurrently in Respir Care. 1984;29:922-35..
[2]
Tarpy SP, Celli B.R..
Long-term oxygen therapy.
N Eng J Med, 333 (1995), pp. 710-714
[3]
Cranston JM, Crockett AJ, Moss JR, Alpers JH. Oxígeno domiciliario para la enfermedad pulmonar obstructiva crónica (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 4. Oxford: Update Software Ltd. [Última modificación 7 de junio de 2005] Disponible en: http://www.update-software. com (Traducida de The Cochrane Library, 2007 Issue 4. Chichester, UK: John Wiley & Sons, Ltd.).
[4]
Medical Research Council Working Party Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet. 1981;1:681-6..
[5]
Nocturnal Oxygen Therapy Trial Group..
Continuous or nocturnal oxygen therapy in hypoxaemic chronic obstructive lung disease.
Ann Intern Med, 93 (1980), pp. 391-398
[6]
Sánchez Agudo L, Cornudella R, Estopá Miró R, Molinos Martín L, Servera Pieras E..
Indicación y empleo de la oxigenoterapia continuada domiciliaria (OCD).
Arch Bronconeumol, 34 (1998), pp. 87-94
[7]
Guyatt G, Nonoyama M, Lacchetti C, Goeree R, McKim D, Heels-Ansdell D, et-al..
A Randomized Trial of Strategies for Assessing Eligibility for Long-Term Domiciliary Oxygen Therapy.
Am J Respir Crit Care Med, 172 (2005), pp. 573-580
[8]
Wedzicha J..
Domiciliary oxygen therapy services: clinical guidelines and advice for prescribers. Summary of a report of the Royal College of Physicians.
J R Coll Physicians Lond, 33 (1999), pp. 445-447
[9]
British Thoracic Society Working Group on Home Oxygen Services. Clinical component on the assessment for provision of home oxygen services in England and Wales. London: British Thoracic Society; 2005. Disponible en: www.brit-thoracic.org.
[10]
Crockett AJ, Cranston JM, Antic N. Oxígeno domiciliario para la enfermedad pulmonary intersticial (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 4. Oxford: Update Software Ltd. [Última modificación 22 de mayo de 2001] Disponible en: http://www.update-software.com (Traducida de The Cochrane Library, 2007 Issue 4. Chichester, UK: John Wiley & Sons, Ltd.).
[11]
Mallory GB, Fullmer JJ, Vaughan DJ. Oxigenoterapia para la fibrosis quística (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 4. Oxford: Update Software Ltd. [Última modificación 24 de agosto de 2005] Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2007 Issue 4. Chichester, UK: John Wiley & Sons, Ltd.).
[12]
Roberts DH, Lepore JJ, Maroo A, Semigran MJ, Ginns L.C..
Oxygentherapy improves cardias index and pulmonaryvascular resistance in patients with pulmonaryhypertension.
Chest, 120 (2001), pp. 1547-1555
[13]
Gorecka D, Gorzelak K, Sliwinski P, Tobiasz M, Zielinski J..
Effect of long term oxygen therapy on survival in chronic obstructive pulmonary disease with moderate hypoxaemia.
Thorax, 52 (1997), pp. 674-679
[14]
Fletcher EC, Donner CF, Midgren B, Zielinski J, Levi-Valensi P, Braghiroli A, et-al..
Survival in COPD patients with a daytime PaO2 greater than 60 mmHg with and without nocturnal oxyhemoglobin desaturation.
Chest, 101 (1992), pp. 649-655
[15]
Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Enrhart M, Schott R, et-al..
A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonarydisease patients.
Eur Respir J, 14 (1999), pp. 1002-1008
[16]
Levi-Valensi P, Weitzenblum E, Pedinielli JL, Racineux J.L..
Three-month follow-up of arterial blood gas determinations in candidates for long-term oxygen therapy.
Am Rev Respir Dis, 133 (1986), pp. 547-551
[17]
Levi-Valensi P, Aubry P, Rida Z..
Nocturnal hypoxaemia and long term oxygen therapy in chronic obstructive pulmonary disease patients with a daytime PaO2 of 60-70 mmHg.
Lung, 168 (1990), pp. 770-775
[18]
Pitkin AD, Roberts CM, Wedzicha J.A..
Arterialised ear lobe blood gas analysis: an underused technique.
Thorax, 49 (1994), pp. 364-366
[19]
Roberts CM, Bugler JR, Melchor R, Hetzel MR, Spiro S.G..
Value of pulse oximetry in screening for long-term oxygen requirement.
Eur Respir J, 6 (1993), pp. 559-562
[20]
Bolton CE, Annandale JA, Ebden P..
Comparison of an oxygen concentrator and wall oxygen in the assessment of patients undergoing long term oxygen therapy assessment.
Chron Respir Dis, 3 (2006), pp. 49-51
[21]
Feu Collado MN, Jurado Gámez B, Rubio Sánchez J, Pascual Martínez N, Escribano Dueñas AA, García Gil F, et-al..
Rentabilidad de la pulsioximetría para el control de la oxigenoterapia domiciliaria.
An Med Interna (Madrid), 21 (2004), pp. 56-61
[22]
Nisbet M, Eaton T, Lewis C, Fergusson W, Kolbe J..
Overnight prescription of oxygen in long term oxygen therapy: time to reconsider the guidelines?.
Thorax, 61 (2006), pp. 779-782
[23]
Lacasse Y, LaForge J, Maltais F..
Got a match? Home oxygen therapy in current smokers.
Thorax, 61 (2006), pp. 374-375
[24]
American Thoracic Society..
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 152 (1995), pp. S77-S120
[25]
Eaton T, Garrett JE, Young P, Fergusson W, Kolbe J, Rudkin S, et-al..
Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study.
Eur Resp J, 20 (2002), pp. 306-312
[26]
Morante F, Güell R, Mayos M..
Eficacia de la prueba de los 6 minutos de marcha en la valoración de la oxigenoterapia de deambulación.
Arch Bronconeumol, 41 (2005), pp. 596-600
[27]
Bradley JM, O’Neill B. Oxígeno ambulatorio a corto plazo para la enfermedad pulmonar obstructiva crónica (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 4. Oxford: Update Software Ltd. [Última modificación 8 de junio de 2005] Disponible en: http://www.update-software.com (Traducida de The Cochrane Library, 2007 Issue 4. Chichester, UK: John Wiley & Sons, Ltd.).
[28]
Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R..
Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients.
Am J Respir Crit Care Med, 168 (2003), pp. 1034-1042
[29]
Nonoyama ML, Brooks D, Lacasse Y, Guyatt GH, Goldstein RS. Oxigenoterapia durante el entrenamiento con ejercicios para la enfermedad pulmonar obstructiva crónica (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 4. Oxford: Update Software Ltd. Disponible en: http://www.updatesoftware.com (Traducida de The Cochrane Library, 2007 Issue 4. Chichester, UK: John Wiley & Sons, Ltd.).
[30]
Bradley JM, Lasserson T, Elborn S, MacMahon J, O’Neill B..
A Systematic Review of Randomized Controlled Trials Examining the Short-term Benefit of Ambulatory Oxygen in COPD.
Chest, 131 (2007), pp. 278-285
[31]
Lacasse Y, Lecours R, Pelletier C, Begin R, Maltais F..
Randomised trial of ambulatory oxygen in oxygen-dependent COPD.
Eur Respir J, 25 (2005), pp. 1032-1038
[32]
Nonoyama ML, Brooks D, Guyatt GH, Goldstein R.S..
Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia.
Am J Respir Crit Care Med, 176 (2007), pp. 343-349
[33]
Ram FSF, Wedzicha JA. Oxígeno ambulatorio para la enfermedad pulmonar obstructive crónica (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 4. Oxford: Update Software Ltd. [Última modificación 27 de noviembre de 2001] Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2007 Issue 4. Chichester, UK: John Wiley & Sons, Ltd.).
[34]
McDonald CF, Blyth CM, Lazarus MD, Marschner I, Barter C.E..
Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxaemia.
Am J Respir Crit Care Med, 152 (1995), pp. 1616-1619
[35]
Restrick LJ, Davies SW, Noone L, Wedzicha J.A..
Ambulatory oxygen in chronic heart failure.
Lancet, 340 (1992), pp. 1192-1193
[36]
Roberts C.M..
Short burst oxygen therapy for relief of breathlessness in COPD.
Thorax, 59 (2004), pp. 638-640
[37]
Quantrill SJ, White R, Crawford A, Barry JS, Batra S, Whyte P, et-al..
Short burst oxygen therapy after activities of daily living in the home in chronic obstructive pulmonary disease.
Thorax, 62 (2007), pp. 702-705
[38]
Gallagher R, Roberts D..
A systematic review of oxygen and airflow effect on relief of dyspnoea at rest in patients with advanced disease of any cause.
J Pain Palliative Care Pharmacother, 18 (2004), pp. 3-15
[39]
Ringbaek J, Viskum K, Lange P..
Does long-term oxygen therapy reduce hospitalization in hypoxaemic chronic obstructive pulmonary disease?.
Eur Respir J, 20 (2002), pp. 38-42
[40]
Bruera E, De Stoutz N, Valsco-Leiva A, Schoeller T, Hanson J..
Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients.
Lancet, 342 (1993), pp. 13-14
[41]
Dheda K, Lim K, Ollivere B, Leftley J, Lampe FC, Salisbury A, et-al..
Assessments for oxygen therapy in COPD: are we under correcting arterial oxygen tensions?.
Eur Respir J, 24 (2004), pp. 954-957
[42]
Wettstein RB, Shelledy DC, Peters J.I..
Delivered oxygen concentrations using lowflow and high-flow nasal cannulas.
Respir Care, 50 (2005), pp. 604-609
[43]
Vain NE, Prudent LM, Stevens DP, Weeter MM, Maisels M.J..
Regulation of oxygen concentration delivered to infants via nasal cannulas.
Am J Dis Child, 143 (1989), pp. 1458-1460
[44]
Castillo D, Rosa Güell R, Casan P..
Sistemas de ahorro de oxígeno. Una realidad olvidada.
Arch Bronconeumol, 43 (2007), pp. 40-45
[45]
Durán J, González Mangado N, Marín JM, Solans M, Zamarrón C, Montserrat J.M..
Concepto, definición y epidemiología.
Arch Bronconeumol, 38 (2002), pp. 3-9
[46]
Jimenez A, Golpe R..
Clínica del síndrome de apnea-hipopnea obstuctiva del sueño (SAOS).
[47]
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S..
The occurrence of sleep disorders breathing among middle-aged adults.
N Engl J Med, 328 (1993), pp. 1230-1236
[48]
Durán J, Esnaola S, Ramón R, Iztueta A..
Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 years.
Am J Respir Crit Care Med, 163 (2001), pp. 685-689
[49]
Marin JM, Gascón JM, Carrizo S, Gispert J.A..
Prevalence of sleep apnoea in the Spanish adult population.
Intern J Epidemiol, 26 (1977), pp. 381-386
[50]
Zamarrón C, Gude F, Otero Y, Álvarez JM, Golpe A, Rodríguez J.R..
Prevalence of sleep disordered breathing and sleep apnea in 50 to 70 year old individuals. A survey.
Respiration, 66 (1999), pp. 317-322
[51]
Baldwin CM, Griffith KA, Nieto FJ, O’Connor GT, Walsleben JA, Redline S..
The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study.
Sleep, 24 (2001), pp. 96-105
[52]
Bixler EO, Vgonzas AN, Lin HM, Have TT, Leib BE, Vela-Bueno A, et-al..
Association of hypertension and sleep-disordered breathing.
Arch Intern Med, 160 (2000), pp. 2289-2295
[53]
Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, et-al..
Population-based study of sleep-disordered breathing as a risk factor for hypertension.
Arch Intern Med, 157 (1997), pp. 1746-1752
[54]
Lavie P, Herer P, Hofstein V..
Obstructive sleep apnea syndrome as a risk factor for hypertension: population study.
BMJ, 320 (2000), pp. 479-482
[55]
Peppard PE, Young T, Palta M, Skatrud J..
Prospective study of the association between sleep-disordered breathing and hypertension.
N Engl J Med, 342 (2000), pp. 1378-1384
[56]
Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et-al..
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study.
JAMA, 283 (2000), pp. 1829-1836
[57]
Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ, et-al..
Sleep-disordered breathing and cardiovascular disease. Crosssectional results of the Sleep Heart Health Study.
Am J Respir Crit Care Med, 163 (2001), pp. 19-25
[58]
Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J..
Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea. A 7-year follow-up.
Am J Crit Care Med, 166 (2002), pp. 159-165
[59]
Bassetti C, Aldrich M.S..
Sleep apnea in acute cerebrovascular disease: final report on 128 patients.
Sleep, 22 (1999), pp. 217-223
[60]
Parra O, Arboix A, Bechich S, García-Eroles L, Montserrat JM, López JA, et-al..
Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack.
Am J Respir Crit Care Med, 161 (2000), pp. 375-380
[61]
Terán-Santos J, Jiménez-Gómez A, Cordero-Guevara J, The Cooperative Group Burgos-Santander..
The association between sleep apnea and the risk of traffic accidents.
N Engl J Med, 340 (1999), pp. 847-851
[62]
Barbé F, Pericás J, Muñoz A, Findley L, Antó JM, Agustí A.G.N..
Automobile accidents in patients with sleep apnea syndrome. An epidemiological and mechanistic study.
Am J Respir Crit Care Med, 158 (1998), pp. 18-22
[63]
He J, Kriger MH, Zorick FJ, Conway W..
Mortality and apnea index in obstructive sleep apnea.
Chest, 94 (1988), pp. 9-14
[64]
Phillipson E.A..
Sleep apnea. A major public health problem.
N Engl J Med, 328 (1993), pp. 1271-1273
[65]
American Thoracic Society..
Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes.
Am J Crit Care Med, 150 (1994), pp. 1738-1745
[66]
Mar J, Rueda JR, Durán-Cantolla J, Schechter C, Chilcott J..
The cost-effectiveness of CPAP treatment in patients with moderate to severe obstructive sleep apnoea.
Eur Respir J, 21 (2003), pp. 515-522
[67]
Kryger MH, Ross L, Delaive K, Walld R, Horrocks J..
Utilization of health care services in patients with severe obstructive sleep apnea.
Sleep, 19 (1996), pp. S111-S116
[68]
Ronald J, Delaive K, Roos L, Manfreda J, Bahammam A, Kryger M.H..
Health care utilization in the 10 years prior to diagnosis in obstructive sleep apnea patients.
Sleep, 2 (1999), pp. 225-229
[69]
Durán Cantolla J, Mar J, De la Torre Muñecas G, Rubio Aramendi R, Guerra L..
El síndrome de apneas-hipopneas durante el sueño en España. Disponibilidad de recursos para su diagnóstico y tratamiento en los hospitales del Estado español.
Arch Bronconeumol, 40 (2004), pp. 259-267
[70]
Capote F, Masa JF, Jiménez A, Peces-Barba G, Amilibia J, Rubio R..
Manifestaciones clínicas del SAHS. Métodos diagnósticos. Síndrome de resistencia aumentada de la vía aérea superior.
Arch Bronconeumol, 38 (2002), pp. 21-27
[71]
Durán Cantolla J, Amilibia Alonso J, Barbé Illá F, Capote Gil F, González Mangado N, Jiménez Gómez A, et-al..
Grupo de Trabajo de Área de Insuficiencia Respiratoria y Trastornos del Sueño. Disponibilidad de recursos técnicos para el diagnóstico y tratamiento del síndrome de apnea obstructiva del sueño en los hospitales de la red pública del estado.
Arch Bronconeumol, 31 (1995), pp. 463-469
[72]
Masa Jiménez JF, Barbé Illa F, Capote Gil F, Chiner Vives E, Díaz de Atauri J, Durán Cantolla J, et-a.l, Grupo Cooperativo..
Recursos y demoras en el diagnóstico del síndrome de apneas-hipopneas durante el sueño (SAHS).
Arch Bronconeumol, 43 (2007), pp. 188-198
[73]
Flemons WW, Douglas NJ, Kuna ST, Rodenstein DO, Wheatley J..
Access to diagnosis and treatment of patients with suspected sleep apnea.
Am J Respir Crit Care Med, 169 (2004), pp. 668-672
[74]
Terán J, Fernández C, Cordero J..
Situación en España de los recursos diagnósticos y de los tratamientos con presión positiva continua sobre la vía aérea, en el síndrome de apneas-hipopneas obstructivas del sueño.
Arch Bronconeumol, 36 (2000), pp. 494-499
[75]
Montserrat JM, Amilibia J, Barbé F, Capote F, Durán J, Mangado NG, et-al..
Grupo de trabajo del Área de Insuficiencia Respiratoria y Trastornos del Sueño (SEPAR). Tratamiento del síndrome de las apneas-hipopneas durante el sueño.
Arch Bronconeumol, 34 (1998), pp. 204-206
[76]
Grupo Español de Sueño (GES)..
Tratamiento del SAHS con presión continua positiva en la vía respiratoria superior (CPAP). Consenso Nacional sobre el síndrome de apneas-hipopneas del sueño.
Arch Bronconeumol, 41 (2005), pp. 51-67
[77]
Lowbe DI, Gay PC, Strohl P, Pack AI, White DP, Collop N.A..
Indications for positive airway pressure treatment of adult obstructive sleep apnea patients. A consensus statement.
Chest, 115 (1999), pp. 863-866
[78]
Kushida CA, Litner MR, Morgenthaler T, Alessi CA, Bailey D, Coleman J, et-al..
Practice parameters for the indications for polysomnography and related procedures: an update for 2005.
Sleep, 38 (2005), pp. 499-521
[79]
Pack AI, Platt AB, Pien G.W..
Does Untreated Obstructive Sleep Apnea Lead to Death?.
Sleep, 31 (2008), pp. 1067-1068
[80]
Marshall NS, Wong K.K.H, Liu PY, Cullen S.R.J, Knuiman MW, Grunstein R.R..
Sleep apnea as an independent risk factor for all-cause mortality, The Busselton Health Study.
Sleep, 31 (2008), pp. 1079-1085
[81]
Young T, Finn L, Peppard P, Szklo-Coxe M, Austin D, Nieto J, et-al..
Sleep-disordered breathing and mortality; Eigtheen-year follow-up of Wisconsin Sleep Cohort.
Sleep, 31 (2008), pp. 1071-1078
[82]
Littner M, Hirshkowitz M, Davila D, Anderson WM, Kushida CA, Woodson BT, et-al..
Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the use of auto-titrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome. An American Academy of Sleep Medicine report.
Sleep, 25 (2002), pp. 143-147
[83]
Masa JF, Jimenez A, Durán J, Capote F, Monasterio C, Mayos M, et-a.l, The Coorperative Spanish Group..
Alternative methods of titrating continuous positive airway pressure. A large multicenter study.
Am J Respir Crit Care Med, 170 (2004), pp. 1218-1224
[84]
Sanders MR, Kern N..
Obstructive sleep apnea treated by independently adjusted inspiratory and expiratory positive airway pressures via nasal mask. Physiological and clinical implications.
Chest, 98 (1990), pp. 317-324
[85]
Dreijer LS, Hemmingsen C, Jacobsen E..
Bi-level positive airway pressure treatment of obstructive sleep apnoea syndrome.
Respiration, 65 (1998), pp. 114-119
[86]
Resta O, Guido P, Picca V, Sabato R, Rizzi M, Scarpelli F, et-al..
Prescription of CPAP and nBIPAP in obstructive sleep apnoea syndrome: Italian experience in 105 subjects. A prospective two centre study.
Respir Med, 92 (1998), pp. 820-827
[87]
Gay P, Weaver T, Loube D, Iber C..
Positive Airway Pressure Task Force; Standards of Practice Committee; American Academy of Sleep Medicine Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults.
Sleep, 29 (2006), pp. 381-401
[88]
Nilius G, Happel A, Domanski U, Ruhle K.H..
Pressure-relief continuous positive airway pressure vs constant continuous positive airway pressure: a comparison of efficacy and compliance.
Chest, 130 (2006), pp. 1018-1024
[89]
Weaver TE, Kribbs NB, Pack AI, Kline LR, Chugh DK, Maislin G, et-al..
Night-tonight variability in CPAP use over the first three months of treatment.
Sleep, 20 (1997), pp. 278-283
[90]
Popescu G, Latham M, Allgar V, Elliott M.W..
Continuous positive airway pressure for sleep apnoea/hypopnoea syndrome: usefulness of a 2 week trial to identify factors associated with long term use.
Thorax, 56 (2001), pp. 727-733
[91]
Budhiraja R, Parthasarathy S, Drake CL, Roth T, Sharief I, Budhiraja P, et-al..
Early CPAP use identifies subsequent adherence to CPAP therapy.
Sleep, 30 (2007), pp. 320-324
[92]
Weaver TE, Grunstein R.R..
Adherence to continuous positive airway pressure therapy: the challenge to effective treatment.
Proc Am Thorac Soc, 5 (2008), pp. 173-178
[93]
Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas N.J..
Self-reported use of CPAP and benefits of CPAP therapy: a patient survey.
Chest, 109 (1996), pp. 1470-1476
[94]
Petty T.L..
The modern evolution of mechanical ventilation.
Clin Chest Med, 9 (1988), pp. 1-10
[95]
Goldberg A.I..
The regional approach to home care for life-supported persons.
Chest, 86 (1984), pp. 345-346
[96]
O’Donohue WJ, Giovannoni RM, Goldberg AI, Keens TG, Make BJ, Plummer AL, et-al..
Long-term mechanical ventilation. Guidelines for management in the home and at alternate community sites. Report of the Ad Hoc Committee, Respiratory Care Section, American College of Chest Physicians.
Chest, 90 (1986), pp. 1S-37S
[97]
Lloyd-Owen SJ, Donalson GC, Ambrosino N, Escarrabil J, Farré R, Fauroux B, et-al..
Home mechanical ventilation in 16 European countries- a mayor survey of custom and practice.
Eur Respir J, 20 (2002), pp. 626s
[98]
Consensus conference. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation. A Consensus Coference Report. Chest. 1999;116:521-34..
[99]
Lisboa C, Díaz O, Fadic R..
Ventilación mecánica no invasiva en pacientes con enfermedades neuromusculares y en pacientes con alteraciones de la caja torácica.
Arch Bronconeumol, 39 (2003), pp. 314-320
[100]
Heinemann F, Budweiser S, Dobroschke J, Pfeifer M.J..
Non-invasive positive pressure ventilation improves lung volumes in the obesity hypoventilation syndrome.
Respir Med, 101 (2007), pp. 1229-1235
[101]
Rodríguez Roisin R, Marrades R.M..
Enfermedad pulmonar obstructiva crónica y ventilación no invasiva: una evidencia creciente.
Arch Bronconeumol, 37 (2001), pp. 88-95
[102]
American Respiratory Care Foundation..
Consensus Conferen non-invasive positive pressure ventilation.
Respir Care, 42 (1997), pp. 364-369
[103]
Wijkstra PJ, Lacasse Y, Guyatt GH, Goldstein R.S..
Nocturnal non-invasive positive ventilation for stable chronic obstructive pulmonary disease.
Cochrane Database Sys Rev, 3 (2002),
[105]
Brochard L, Mancebo J..
Ventilación artificial.
Ventilación artificial, (1996),
[106]
Mehta S, Hill N.S..
Noninvasive ventilation.
Am J Respir Crit Care Med, 163 (2001), pp. 540-577
[107]
Elliot MW, Mulvey DA, Moxham J, Green M, Branthwaite M.A..
Domiciliary nocturnal nasal intermittent positive pressure ventilation: mechanisms underlying changes in arterial blood gas tensions.
Eur Respir J, 1 (1991), pp. 1044-1052
[108]
Marcy T.W..
Inverse ratio ventilation.
, pp. 31
[109]
Eissa NT, Ranieri VM, Corbeil C, Chassé M, Braidy J, Milic-Emili J..
Effects of PEEP on the mechanics of the respiratory system in ARDS patients.
J Appl Physiol, 73 (1992), pp. 1728-1735
[110]
Parreira VF, Delguste P, Jounieaux V, Aubert G, Dury M, Rodenstein D.O..
Effectiveness of controlled and spontaneous modes in nasal two-level positive pressure ventilation in awake and asleep normal subjects.
Chest, 112 (1997), pp. 1267-1277
[111]
Elliott M.W..
The interfa crucial for successful noninvasive ventilation.
Eur Respir J, 23 (2004), pp. 7-8
[112]
Willson GN, Piper AJ, Norman M, Chaseling WG, Milross MA, Collins ER, et-al..
Nasal versus full face mask for noninvasive ventilation in chronic respiratory failure.
Eur Respir J, 23 (2004), pp. 605-609
[113]
Holland AE, Denehy L, Buchan CA, Wilson J.W..
Efficacy of a heated passover humidifier during noninvasive ventilation: a bench study.
Respir Care, 52 (2007), pp. 38-44
[114]
Servera E, Sancho J, Zafra M.J..
Cough and neuromuscular diseases. Noninvasive airway secretion management.
Arch Bronconeumol, 39 (2003), pp. 418-427
[115]
Bach J.R..
Mechanical insufflation-exsufflation: comparison of peak expiratory flor with manually assisted and unassited coughing techniques.
Chest, 104 (1993), pp. 1553-1562
[116]
Chatwin M, Ross E, Hart N, Nickol AH, Polkey MI, Simonds A.K..
Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness.
Eur Respir J, 21 (2003), pp. 502-508
[117]
Sancho J, Servera E, Díaz J, Marín J..
Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis.
Chest, 125 (2004), pp. 1400-1405
[118]
Vianello A, Corrado A, Arcaro G, Gallan F, Ori C, Minuzzo M, et-al..
Mechanical insufflation-exsufflation improves outcomes for neuromuscular disease patients with respiratory tract infections.
Am J Phys Med Rehabil, 84 (2005), pp. 83-88
[119]
Eaton T, Young P, Zeng I, Kolbe J..
A randomized evaluation of the acute efficacy, acceptability and tolerability of flutter and active cycle of breathing with and without postural drainage in noncystic fibrosis bronchiectasis.
Chron Respir Dis, 4 (2007), pp. 23-30
[120]
Patterson JE, Hewitt O, Kent L, Bradbury I, Elborn JS, Bradley J.M..
Acapella versus ‘usual airway clearance’ during acute exacerbation in bronchiectasis: a randomized crossover trial.
Chron Respir Dis, 4 (2007), pp. 67-74
[121]
Elkins MR, Jones A, Van der Schans C..
Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.
Cochrane Database Sys Rev, (2006),
[122]
Dennis J.H..
A review of issues relating to nebulizer standards.
J Aerosol Med, 11 (1998), pp. 73-79
[123]
Cates CJ, Crilly JA, Rowe B.H..
Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma.
Cochrane Database Syst Rev, 2 (2006),
[124]
Boe J, Dennis JH, O’Driscoll BR, Bauer TT, Carone M, Dautzenberg B, et-al..
European Respiratory Society Guidelines Task Force on the use of nebulizers. European Respiratory Society Guidelines on the use of nebulizers.
Eur Respir J, 18 (2001), pp. 228-242
[125]
Jones AP, Wallis C.E..
Recombinant human deoxyribonuclease for cystic fibrosis.
Cochrane Database Syst Rev, 3 (2003),
[126]
Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, et-al..
National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.
N Engl J Med, 354 (2006), pp. 229-240
[127]
Ramsey BW, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Kravitz RM, et-al..
Efficacy of aerosolized tobramycin in patients with cystic fibrosis.
N Engl J Med, 328 (1993), pp. 1740-1746
[128]
Vendrell M, De Gracia J, Olveira C, Martínez MA, Girón R, Máiz L, et-al..
Normativa SEPAR. Diagnóstico y tratamiento de las bronquiectasias.
Arch Bronconeumol, 44 (2008), pp. 629-640
[129]
De Gracia J, Máiz L, Prados C, Vendrell M, Baranda F, Escribano A, et-al..
Antibióticos nebulizados en pacientes con fibrosis quística.
Med Clin (Barc), 117 (2001), pp. 233-237
[130]
Monforte V, Roman A, Gavalda J, Bravo C, Tenorio L, Ferrer A, et-al..
Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors.
J Heart Lung Transplant, 20 (2001), pp. 1274-1281
[131]
Smego RA, Nagar S, Maloba B, Popara M..
A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia.
Arch Intern Med, 161 (2001), pp. 1529-1533
[132]
Olschewski H, Simmonneau G, Galiè N, Higenbottam T, Naeije R, Rubin LJ, et-a.l, Aerosolized Iloprost Randomized Study Group..
Inhaled iloprost for severe pulmonary hypertension.
N Engl J Med, 347 (2002), pp. 322-329
[133]
Iacono AT, Johnson BA, Grgurich WF, Youssef JG, Corcoran TE, Seiler DA, et-al..
A randomized trial of inhaled cyclosporine in lung-transplant recipients.
N Engl J Med, 354 (2006), pp. 141-150
[134]
Nikander K, Turpeinen M, Wollmer P..
The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension.
J Aerosol Med, 12 (1999), pp. 47-53
[135]
Devadason SG, Everard ML, Linto JM, Le Souëf P.N..
Comparison of drug delivery from conventional versus Venturi nebulizers.
Eur Respir J, 10 (1997), pp. 2479-2483
[136]
Balmes JR, Chaisson R, Dolovich MB, Fallat R, Kacmarck RM, Matthys H, et-al..
Aerosol Consensus Statement.
Chest, 100 (1991), pp. 1106-1119
[137]
Kendrick AH, Smith EC, Denyer J..
Nebulizers-fill volume, residual volume and matching of nebulizer to compressor.
Respir Med, 89 (1995), pp. 157-159
[138]
Raul JL, Ari A, Restrepo R.D..
Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric.
Respir Care, 49 (2004), pp. 174-179
[139]
Dhan R..
Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol.
Respir Care, 47 (2002), pp. 1406-1416
